CYTOSPONGE
Device
COVIDIEN LP
Total Payments
$105,284
Transactions
15
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $105,284 | 15 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $105,248 | 14 | 100.0% |
| Food and Beverage | $36.43 | 1 | 0.0% |
Payments by Type
Research
$105,248
14 transactions
General
$36.43
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CASE II CYTOSPONGE | COVIDIEN LP | $105,248 | 0 |
Top Doctors Receiving Payments for CYTOSPONGE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $105,248 | 14 |
| , M.D | Specialist | Phoenix, AZ | $36.43 | 1 |
Ad
Manufacturing Companies
- COVIDIEN LP $105,284
Product Information
- Type Device
- Total Payments $105,284
- Total Doctors 1
- Transactions 15
About CYTOSPONGE
CYTOSPONGE is a device associated with $105,284 in payments to 1 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is COVIDIEN LP.
Payment data is available from 2018 to 2018. In 2018, $105,284 was paid across 15 transactions to 1 doctors.
The most common payment nature for CYTOSPONGE is "Unspecified" ($105,248, 100.0% of total).
CYTOSPONGE is associated with 1 research study, including "CASE II CYTOSPONGE" ($105,248).